BRAEBURN INC. FORMERLY KNOWN AS BRAEBURN PHARMACEUTICALS INC for BRAEBURN INC FORMERLY KNOWN AS BRAEBURN PHARMACEUTICALS INC
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
General lobbying pertaining to opioid crisis, including amendments to the Orphan Drug Act HR 4712-Fairness in Orphan Drug Exclusivity Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| EDWARD BUCKLEY | — |
Pharmacy PHA
General lobbying pertaining to opioid crisis, including amendments to the Orphan Drug Act HR 4712-Fairness in Orphan Drug Exclusivity Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| EDWARD BUCKLEY | — |
Medicare/Medicaid MMM
General lobbying pertaining to opioid crisis, including amendments to the Orphan Drug Act HR 4712-Fairness in Orphan Drug Exclusivity Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| EDWARD BUCKLEY | — |
Insurance INS
General lobbying pertaining to opioid crisis, including amendments to the Orphan Drug Act HR 4712-Fairness in Orphan Drug Exclusivity Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| EDWARD BUCKLEY | — |
Alcohol and Drug Abuse ALC
General lobbying pertaining to opioid crisis, including amendments to the Orphan Drug Act HR 4712-Fairness in Orphan Drug Exclusivity Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| EDWARD BUCKLEY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.